Background/Aims
We evaluated the prognostic value of the pretreatment elevation of tumor markers for hepatocellular carcinoma (HCC) in patients who underwent curative treatment.
Conclusions
The prognostic value of pretreatment tumor marker elevation was different in patients who underwent the curative treatment according to the type of treatment. Pretreatment elevation of AFP-L3 and DCP had prognostic values only in patients treated with LTA.
Associate Editor: M. Colombo
Journal of Hepatology
DOI: 10.1016/j.jhep.2008.04.013